Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 May;20(5):511-515.
doi: 10.22038/IJBMS.2017.8675.

Berberine Protects Against Metformin-Associated Lactic Acidosis in Induced Diabetes Mellitus

Free PMC article

Berberine Protects Against Metformin-Associated Lactic Acidosis in Induced Diabetes Mellitus

Suhail Ahmed Almani et al. Iran J Basic Med Sci. .
Free PMC article


Objectives: Causality of occurrence of metformin-associated lactic acidosis (MALA) is a clinical problem. Currently, there is no drug available to prevent MALA. The present study was conducted to evaluate the protective effect of Berberine (BBR) against MALA in induced diabetic rat model.

Materials and methods: A sample of 75 healthy male Wistar rats was randomly selected according to inclusion and exclusion criteria. 75 male Wistar rats were randomly divided into a control and 4 experimental groups. Streptozotocin (STZ) in citrate buffer (pH 4.5) at a dose of 45 mg/kg was injected for induction of diabetes mellitus and rats achieving fasting blood glucose >250 mg/dl were included. Blood samples were collected 18 hr after the last dose of metformin and berberine. Ethical approval was taken before the study was conducted. Staistix 10.0 (USA) software was used for data analysis.

Results: Berberine decreased MALA. Metformin, metformin + BBR 50 mg/kg bwt, and metformin + BBR 100 mg/kg bwt showed serum lactate as 1.87±0.4 mmol/lL, 1.62 ± 0.44 mmol/l and 1.47± 0.45 mmol/l, respectively (P=0.0001). Insulin resistance and liver enzymes were improved in BBR treated rats.

Conclusion: The present study reports berberine protects against MALA in streptozocin-induced diabetes mellitus.

Keywords: Berberine; Insulin resistance; Lactic acidosis; Metformin.

Similar articles

See all similar articles

Cited by 3 articles


    1. Zafar J, Nadeem D, Khan SA, Jawad Abbasi MM, Aziz F, Saeed S. Prevalence of diabetes and its correlates in urban population of Pakistan:A Cross-sectional survey. J Pak Med Assoc. 2016;66:922–927. - PubMed
    1. Lepelley M, Giai J, Yahiaoui N, Chanoine S, Villierr C. Lactic acidosis in diabetic population:is metformin implicated?results of a matched case-control study performed on the Type 2 diabetes population of grenoble hospital university. J Diabet Res. 2016;2106:3545914. - PMC - PubMed
    1. Inzucchi SE, Bergenstal RM, Buse JB. Management of hyperglycemia in type 2 diabetes:a patient centered approach position statement of the American Diabetes Association (ADA) and European Association for the Study of Diabetes (EASD) Diabetol. 2012;55:1577–1596. - PubMed
    1. Turner RC, Cull CA, Frighi V, Holman RR. Glycemic control with diet, sulfonylurea, metformin or insulin in patients with type 2 diabetes mellitus. Progressive requirement for multiple therapies (UKPDS 49) J Am Med Assoc. 2012;281:2005–2012. - PubMed
    1. Lalau JD. Lactic acidosis induced by metformin:incidence, management and prevention. Drug Safety. 2010;33:727–740. - PubMed

LinkOut - more resources